References
- KhattakWIncidence of prostate cancer following trans-urethral resection of prostate (TURP) for clinically benign symptomatic enlarged prostate with normal prostatic specific antigen (PSA)Ophthalmology2014122151
- CalCUsluRGunaydinGOzyurtCOmaySBDoxazosin: a new cytotoxic agent for prostate cancer?BJU Int200085667267510759663
- KehindeEOMojiminiyiOASheikhMAge specific reference levels of serum prostate specific antigen and prostate volume in healthy Arab menBJU Int200596330831216042719
- KarimHHoodaMIslamMIncidence of chips positive carcinoma of prostate following TURP for clinically benign prostatic hyperplasia patients with normal serum PSABangladesh J Urol20111411418
- KurahashiNSasazukiSIwasakiMInoueMTsuganeSJPHC Study GroupGreen tea consumption and prostate cancer risk in Japanese men: a prospective studyAm J Epidemiol20081671717717906295
- MariottoABEtzioniRKrapchoMFeuerEJReconstructing PSA testing patterns between black and white men in the US from Medicare claims and the National Health Interview SurveyCancer200710991877188617372918
- StattinPCarlssonSHolmströmBProstate cancer mortality in areas with high and low prostate cancer incidenceJ Natl Cancer Inst20141063dju00724610909
- D’AmbrosioGGCampoSCancianMPecchioliSMazzagliaGOpportunistic prostate-specific antigen screening in Italy: 6 years of monitoring from the Italian general practice databaseEur J Cancer Prev201019641341620679895
- Napal LecumberriSLameiro CousoFJRubio NavarroCGómez DorronsoroMLarrínaga LiñeroBIpiéns AznarAEstudio de la progresión del cáncer de próstata incidental según el tipo de tratamiento aplicado [A study of the progression of the incidental prostate cancer depending on the kind of treatment performed]Actas Urol Esp2007318810818 Spanish18020204
- Herranz-AmoFDiez-CorderoJMVerdu-TartajoFBueno-ChomonGLeal-HernandezFBielsa-CarrilloANeed for intravenous urography in patients with primary transitional carcinoma of the bladder?Eur Urol199936322122410450006
- FernándezREGómezVFAlvarezCLRuibalMMChantadaAVGonzálezMMEstudio clínico-patológico sobre el cáncer de próstata incidental en pacientes intervenidos bajo el supuesto diagnóstico de HBP sintomática [Clinicopathological study of incidental cancer prostate in patients undergoing surgery for symptomatic diagnosis of BPH]Actas Urol Esp20063013337 Spanish16703727
- MaiKTIsotaloPAGreenJPerkinsDGMorashCCollinsJPIncidental prostatic adenocarcinomas and putative premalignant lesions in TURP specimens collected before and after the introduction of prostrate-specific antigen screeningArch Pathol Lab Med2000124101454145611035574
- YangXMonnMFLiuLIncidental prostate cancer in Asian men: high prevalence of incidental prostatic adenocarcinoma in Chinese patients undergoing radical cystoprostatectomy for treatment of bladder cancer and selection of candidates for prostate sparing cystectomyProstate201575884585425704311
- ZigeunerRSchipsLLipskyKDetection of prostate cancer by TURP or open surgery in patients with previously negative transrectal prostate biopsiesUrology200362588388714624913
- TombalBDe VisccherLCosynsJPAssessing the risk of unsuspected prostate cancer in patients with benign prostatic hypertrophy: a 13-year retrospective study of the incidence and natural history of T1a-T1b prostate cancersBJU Int19998491015102010571626
- VoigtSHüttigFKochRRisk factors for incidental prostate cancer who should not undergo vaporization of the prostate for benign prostate hyperplasia?Prostate201171121325133121308716
- JonesJSFollisHWJohnsonJRProbability of finding T1a and T1b (incidental) prostate cancer during TURP has decreased in the PSA eraProstate Cancer Prostatic Dis2009121576018379587
- HelfandBTAndersonCBFoughtAKimDYVyasAMcVaryKTPostoperative PSA and PSA velocity identify presence of prostate cancer after various surgical interventions for benign prostatic hyperplasiaUrology200974117718319428074
- YooCOhCYKimSJPreoperative clinical factors for diagnosis of incidental prostate cancer in the era of tissue-ablative surgery for benign prostatic hyperplasia: a Korean multi-center reviewKorean J Urol201253639139522741046
- LeeLSThiruneelakandasivamSHongMKAre transrectal prostate biopsies routinely indicated in patients with incidentally diagnosed prostate cancer following transurethral resection of the prostate for benign disease?Urol Int201391439740323921216
- LeeDHChungDYLeeKSClinical experiences of incidental prostate cancer after transurethral resection of prostate (TURP) according to initial treatment: a study of a Korean high volume centerYonsei Med J2014551788324339290
- TrpkovKThompsonJKulagaAYilmazAHow much tissue sampling is required when unsuspected minimal prostate carcinoma is identified on transurethral resection?Arch Pathol Lab Med200813281313131618684032
- OttoBBarbieriCLeeRIncidental prostate cancer in transurethral resection of the prostate specimens in the modern eraAdv Urol2014201462729024876835
- BellKJDel MarCWrightGDickinsonJGlasziouPPrevalence of incidental prostate cancer: a systematic review of autopsy studiesInt J Cancer201513771749175725821151
- KitamuraHMasumoriNTanumaYDoes transurethral resection of the prostate facilitate detection of clinically significant prostate cancer that is missed with systematic sextant and transition zone biopsies?Int J Urol200292959912028299
- van RenterghemKVan KoeveringeGAchtenRvan KerrebroeckPA new algorithm in patients with elevated and/or rising prostate-specific antigen level, minor lower urinary tract symptoms, and negative multisite prostate biopsiesInt Urol Nephrol2010421293819496018
- KimDKKimSJMoonHSThe role of TURP in the detection of prostate cancer in BPH patients with previously negative prostate biopsyKorean J Urol201051531331720495693